At POLITICO Summit, top drug lobbyist calls Trump’s efforts to codify his signature drug pricing deals 'the wrong policy prescription'

PhRMA CEO Stephen Ubl applauded the Trump administration for pressuring other nations to pay more, but says he is against efforts to make White House “most-favored-nation” agreements permanent